ViroGates Statistics

Total Valuation

ViroGates has a market cap or net worth of DKK 71.16 million. The enterprise value is 65.23 million.

Market Cap	71.16M
Enterprise Value	65.23M

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

ViroGates has 7.73 million shares outstanding. The number of shares has increased by 20.01% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	+20.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.61%
Owned by Institutions (%)	n/a
Float	2.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.45
PB Ratio	8.88
P/TBV Ratio	8.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.82
EV / Sales	9.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.66.

Current Ratio	4.24
Quick Ratio	3.60
Debt / Equity	0.66
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.02

Financial Efficiency

Return on equity (ROE) is -126.35% and return on invested capital (ROIC) is -53.10%.

Return on Equity (ROE)	-126.35%
Return on Assets (ROA)	-46.98%
Return on Invested Capital (ROIC)	-53.10%
Return on Capital Employed (ROCE)	-110.75%
Revenue Per Employee	972,571
Profits Per Employee	-1.93M
Employee Count	10
Asset Turnover	0.38
Inventory Turnover	0.78

Taxes

Income Tax	-786,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.58% in the last 52 weeks. The beta is 1.15, so ViroGates's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+29.58%
50-Day Moving Average	7.41
200-Day Moving Average	9.28
Relative Strength Index (RSI)	65.05
Average Volume (20 Days)	3,159

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViroGates had revenue of DKK 6.81 million and -13.53 million in losses. Loss per share was -1.75.

Revenue	6.81M
Gross Profit	4.14M
Operating Income	-13.60M
Pretax Income	-14.32M
Net Income	-13.53M
EBITDA	n/a
EBIT	-13.60M
Loss Per Share	-1.75

Full Income Statement

Balance Sheet

The company has 11.23 million in cash and 5.30 million in debt, giving a net cash position of 5.93 million or 0.77 per share.

Cash & Cash Equivalents	11.23M
Total Debt	5.30M
Net Cash	5.93M
Net Cash Per Share	0.77
Equity (Book Value)	8.01M
Book Value Per Share	1.04
Working Capital	12.10M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.13M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.74%, with operating and profit margins of -199.82% and -198.78%.

Gross Margin	60.74%
Operating Margin	-199.82%
Pretax Margin	-210.33%
Profit Margin	-198.78%
EBITDA Margin	n/a
EBIT Margin	-199.82%
FCF Margin	n/a

Dividends & Yields

ViroGates does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.01%
Shareholder Yield	n/a
Earnings Yield	-19.02%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ViroGates has an Altman Z-Score of 3.18 and a Piotroski F-Score of 2.

Altman Z-Score	3.18
Piotroski F-Score	2